Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
18 Feb 2022
Historique:
received: 21 12 2021
revised: 29 01 2022
accepted: 01 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 3 3 2022
Statut: epublish

Résumé

Protein N-terminal methyltransferase 1 (NTMT1) recognizes a unique N-terminal X-P-K/R motif (X represents any amino acid other than D/E) and transfers 1-3 methyl groups to the N-terminal region of its substrates. Guided by the co-crystal structures of NTMT1 in complex with the previously reported peptidomimetic inhibitor DC113, we designed and synthesized a series of new peptidomimetic inhibitors. Through a focused optimization of DC113, we discovered a new cell-potent peptidomimetic inhibitor GD562 (IC

Identifiants

pubmed: 35209173
pii: molecules27041381
doi: 10.3390/molecules27041381
pmc: PMC8874984
pii:
doi:

Substances chimiques

Enzyme Inhibitors 0
Peptidomimetics 0
Methyltransferases EC 2.1.1.-
NTMT1 protein, human EC 2.1.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM117275
Pays : United States
Organisme : National Institute of Health
ID : GM117275

Références

Chembiochem. 2019 Apr 15;20(8):976-984
pubmed: 30479015
Pharm Res. 2008 Jul;25(7):1511-20
pubmed: 18185985
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9184-9
pubmed: 9689055
J Biol Chem. 2014 Jun 6;289(23):16046-56
pubmed: 24753253
J Med Chem. 2020 Sep 10;63(17):9512-9522
pubmed: 32689795
ACS Med Chem Lett. 2021 Mar 01;12(3):485-493
pubmed: 33738076
Photochem Photobiol. 2006 May-Jun;82(3):695-701
pubmed: 16435882
J Am Chem Soc. 2008 Aug 20;130(33):10854-5
pubmed: 18652453
Biochem J. 2013 Dec 15;456(3):453-62
pubmed: 24090352
J Chem Theory Comput. 2011 Sep 13;7(9):2728-2739
pubmed: 22125476
Protein Sci. 2017 Aug;26(8):1639-1652
pubmed: 28556566
Nat Commun. 2017 Mar 07;8:14678
pubmed: 28266506
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Protein Sci. 2009 Jan;18(1):247-51
pubmed: 19177368
Cell Death Dis. 2021 Oct 28;12(11):1014
pubmed: 34711807
Nat Cell Biol. 2007 May;9(5):596-603
pubmed: 17435751
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
J Proteome Res. 2015 Jun 5;14(6):2575-82
pubmed: 25886813
Eur J Pharm Sci. 2001 Dec;14(4):271-80
pubmed: 11684401
Chem Sci. 2019 Aug 9;10(35):8094-8099
pubmed: 31857877
Biochem Biophys Res Commun. 2021 Mar 26;546:54-58
pubmed: 33561748
Oncotarget. 2015 May 20;6(14):12248-63
pubmed: 25909287
Pharmacol Res. 2021 Oct;172:105814
pubmed: 34450313
J Med Chem. 1998 Mar 26;41(7):1007-10
pubmed: 9544199
Mar Drugs. 2021 May 27;19(6):
pubmed: 34072121
J Chem Theory Comput. 2017 Mar 14;13(3):1439-1453
pubmed: 28103438
Nature. 2010 Aug 26;466(7310):1125-8
pubmed: 20668449

Auteurs

Guangping Dong (G)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.

Iredia D Iyamu (ID)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.

Jonah Z Vilseck (JZ)

Department of Biochemistry and Molecular Biology, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Dongxing Chen (D)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.

Rong Huang (R)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH